Goldman Sachs’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.4M | Buy |
984,734
+5,191
| +0.5% | +$124K | ﹤0.01% | 2249 |
|
|
2025
Q4 | $22.9M | Sell |
979,543
-27,692
| -3% | -$617K | ﹤0.01% | 2254 |
|
|
2025
Q3 | $19.8M | Sell |
1,007,235
-1,404,425
| -58% | -$28.9M | ﹤0.01% | 2271 |
|
|
2025
Q2 | $52.3M | Sell |
2,411,660
-723,813
| -23% | -$17.1M | 0.01% | 1302 |
|
|
2025
Q1 | $76M | Buy |
3,135,473
+333,100
| +12% | +$7.5M | 0.01% | 940 |
|
|
2024
Q4 | $58.5M | Buy |
2,802,373
+1,330,120
| +90% | +$28.6M | 0.01% | 1164 |
|
|
2024
Q3 | $29.3M | Buy |
1,472,253
+384,122
| +35% | +$7.12M | ﹤0.01% | 1707 |
|
|
2024
Q2 | $16.9M | Buy |
1,088,131
+86,850
| +9% | +$1.35M | ﹤0.01% | 2026 |
|
|
2024
Q1 | $16M | Buy |
1,001,281
+42,868
| +4% | +$646K | ﹤0.01% | 2030 |
|
|
2023
Q4 | $16.1M | Sell |
958,413
-9,906
| -1% | -$135K | ﹤0.01% | 2109 |
|
|
2023
Q3 | $11.3M | Sell |
968,319
-282,209
| -23% | -$3.77M | ﹤0.01% | 2289 |
|
|
2023
Q2 | $16.8M | Buy |
1,250,528
+113,791
| +10% | +$1.64M | ﹤0.01% | 1993 |
|
|
2023
Q1 | $18.8M | Buy |
1,136,737
+372,774
| +49% | +$6.15M | ﹤0.01% | 1863 |
|
|
2022
Q4 | $14.2M | Buy |
763,963
+43,837
| +6% | +$675K | ﹤0.01% | 2257 |
|
|
2022
Q3 | $9.24M | Sell |
720,126
-1,190,538
| -62% | -$14.1M | ﹤0.01% | 2584 |
|
|
2022
Q2 | $13.4M | Buy |
1,910,664
+807,303
| +73% | +$5.92M | ﹤0.01% | 2233 |
|
|
2022
Q1 | $9.15M | Buy |
1,103,361
+381,435
| +53% | +$2.7M | ﹤0.01% | 2782 |
|
|
2021
Q4 | $4.89M | Buy |
721,926
+7,069
| +1% | +$46.5K | ﹤0.01% | 3431 |
|
|
2021
Q3 | $3.79M | Sell |
714,857
-353,290
| -33% | -$1.93M | ﹤0.01% | 3592 |
|
|
2021
Q2 | $6.14M | Sell |
1,068,147
-353,846
| -25% | -$1.83M | ﹤0.01% | 3154 |
|
|
2021
Q1 | $6.56M | Sell |
1,421,993
-1,800,597
| -56% | -$7.15M | ﹤0.01% | 2902 |
|
|
2020
Q4 | $10.8M | Buy |
3,222,590
+691,102
| +27% | +$2.32M | ﹤0.01% | 2391 |
|
|
2020
Q3 | $7.52M | Buy |
2,531,488
+461,248
| +22% | +$1.8M | ﹤0.01% | 2569 |
|
|
2020
Q2 | $9.56M | Buy |
2,070,240
+105,776
| +5% | +$475K | ﹤0.01% | 2304 |
|
|
2020
Q1 | $7.56M | Buy |
1,964,464
+37,469
| +2% | +$154K | ﹤0.01% | 2305 |
|
|
2019
Q4 | $7.23M | Buy |
1,926,995
+959,032
| +99% | +$4.48M | ﹤0.01% | 2678 |
|
|
2019
Q3 | $5.14M | Buy |
967,963
+906,407
| +1,472% | +$4.83M | ﹤0.01% | 2842 |
|
|
2019
Q2 | $236K | Sell |
61,556
-25,933
| -30% | -$112K | ﹤0.01% | 4716 |
|
|
2019
Q1 | $447K | Buy |
87,489
+34,679
| +66% | +$102K | ﹤0.01% | 4465 |
|
|
2018
Q4 | $101K | Sell |
52,810
-285,757
| -84% | -$818K | ﹤0.01% | 4994 |
|
|
2018
Q3 | $1.28M | Sell |
338,567
-120,395
| -26% | -$377K | ﹤0.01% | 3894 |
|
|
2018
Q2 | $1.43M | Buy |
458,962
+22,310
| +5% | +$67.7K | ﹤0.01% | 3839 |
|
|
2018
Q1 | $1.04M | Buy |
436,652
+70,274
| +19% | +$234K | ﹤0.01% | 4018 |
|
|
2017
Q4 | $1.43M | Buy |
366,378
+320,810
| +704% | +$1.06M | ﹤0.01% | 4047 |
|
|
2017
Q3 | $115K | Buy |
45,568
+26,716
| +142% | +$73.3K | ﹤0.01% | 6005 |
|
|
2017
Q2 | $52K | Buy |
18,852
+198
| +1% | +$413 | ﹤0.01% | 6350 |
|
|
2017
Q1 | $36K | Sell |
18,654
-24,325
| -57% | -$31K | ﹤0.01% | 6372 |
|
|
2016
Q4 | $45K | Sell |
42,979
-130,421
| -75% | -$149K | ﹤0.01% | 6411 |
|
|
2016
Q3 | $189K | Sell |
173,400
-16,207
| -9% | -$14.6K | ﹤0.01% | 5864 |
|
|
2016
Q2 | $135K | Buy |
189,607
+87,752
| +86% | +$70.7K | ﹤0.01% | 5970 |
|
|
2016
Q1 | $119K | Buy |
101,855
+73,958
| +265% | +$115K | ﹤0.01% | 5979 |
|
|
2015
Q4 | $68K | Buy |
+27,897
| New | +$79.9K | ﹤0.01% | 6393 |
|
|
2015
Q3 | – | Sell |
-11,942
| Closed | -$49K | – | 7296 |
|
|
2015
Q2 | $49K | Sell |
11,942
-90,982
| -88% | -$363K | ﹤0.01% | 6864 |
|
|
2015
Q1 | $446K | Buy |
102,924
+84,222
| +450% | +$304K | ﹤0.01% | 5254 |
|
|
2014
Q4 | $56K | Buy |
18,702
+6,482
| +53% | +$17.8K | ﹤0.01% | 6775 |
|
|
2014
Q3 | $41K | Buy |
+12,220
| New | +$31.9K | ﹤0.01% | 6873 |
|
Other funds holding CPRX
VCM
DM
VPM